Global Microfluidic Devices Market (By Device Type, Material, Application, Industry and Region), Key Company Profiles, Trends, SWOT Analysis, and Recent Developments - Forecast to 2030

Global Microfluidic Devices Market (By Device Type, Material, Application, Industry and Region), Key Company Profiles, Trends, SWOT Analysis, and Recent Developments - Forecast to 2030

The global microfluidic devices market is predicted to reach US$ 45.18 Billion by 2030, from US$ 17.68 Billion in 2023. Microfluidics is a huge potential area of science which allows high–throughput screening and experimentation that revolve around a series of techniques. The technology is used for processing and manipulating small amounts of liquids using channels that possess micrometer dimensions. Microfluidic devices were initially fabricated from silicon and glass materials using microfabrication techniques developed within the semiconductor industry, namely, photolithography and etching. However, the use of polymeric materials for fabrication of microfluidic devices has grown exponentially in the last decade as a result of a significant increase in the availability of polymeric materials with different chemical, mechanical, electrical, and optical properties. With the continuous advancements in biotechnology domain, microfluidic devices promise to be of huge commercial importance. Companies today are focusing on the development of advanced microfluidic devices for various applications by optimizing its speed and sensitivity while minimizing their size and cost. The factors such as the rising demand for POC testing, high incidence of lifestyle diseases, technological advancements, increasing focus on data precision & accuracy, fast returns on investment and faster testing & improved portability through microfluidic chip miniaturization, are driving the market.

Recent Developments

In January 2024, Standard BioTools Inc. completed its merger with SomaLogic, creating a leading provider of differentiated multi-omics tools for research.
In July 2023, Unchained Labs acquired Blacktrace Holdings. Blacktrace Group designs, develops and manufactures cutting-edge technologies and products for many applications in chemistry, microfluidics, biology, nanomaterial sciences and more.
In November 2022, Hamilton announced that it is expanding its microfluidics product range with the acquisition of the microdosing company, BioFluidix.
In October 2022, Standard BioTools launched X9 Real-time PCR System by using microfluidics technology to provide a flexible and productive high-capacity genomics platform.

By Device Type: Global Microfluidic Devices Market and Forecast – Key Takeaways

The chips segment accounted for maximum share of the microfluidic devices market in 2023, owing to high potential in varied applications such as life science, biomedical, drug delivery, immunoassays, diagnostics, and many others.
Sensors is the second leading segment for microfluidic devices market. The adoption of microfluidic sensors in the healthcare sector drives the market growth as they are used for various applications such as drug development, chemical and biological research, medical diagnostics, environmental monitoring, among others.
Micro pumps are the key component that allows the motion of fluids in an accurate and reliable manner through a device’s reservoirs, chambers and microchannels. Globally, the market for microfluidic pumps is gaining significant importance due to growing R&D investment in life sciences, pharmaceuticals, and increasing point of care testing demand.

By Material: Global Microfluidic Devices Market and Forecast – Key Takeaways

In 2023, the polymers segment accounted for highest share of the global microfluidic devices market, as polymers are cheaper material and allow for quick fabrication processes in comparison to silicon and glass. The polydimethylsiloxane (PDMS) is a widely used polymer, especially in fast prototyping microfluidic devices.
Silicon and glass were the original materials first used for microfluidic applications. Silicon was first selected due to its resistance to organic solvents, ease in metal depositing, high thermo–conductivity, and stable electroosmotic mobility. Today, silicon is less employed due to its high cost and its opacity that makes optical detection unreachable, except for infrared (IR).

By Application: Global Microfluidic Devices Market and Forecast – Key Takeaways

Pharmaceutical and life sciences research accounted for largest share of the microfluidic devices market in 2023, followed by the Clinical and veterinary diagnostics segment.
Point–of–care diagnostic devices founded in microfluidic technologies will lead the change to personalized medicine, thereby, having a great effect in the diagnosis and treatment of diseases. Methods in microfabrication and microfluidics have progressed so much in the last few years that POC devices can be fabricated at low cost, are easy to use, portable, and can generate rapid results.
Analytical devices and Drug delivery application segments are competing very closely with each other to grab maximum share of the pie.

By Industry: Global Microfluidic Devices Market and Forecast – Key Takeaways

In–vitro diagnostics is the largest segment type by industry, accounting for over 50% share of the microfluidic devices market in 2023.
Microfluidic technologies are emerging as powerful tools for the drug discovery and development processes. In pharmaceutical industry; its applications are found in the areas of diagnostics and drug research.
Medical devices industry is the fastest growing segment of the microfluidic devices market. The technological advancements in medical devices such as miniaturization, automation and enhanced functionality with help of complex electrical control, and mechanical properties are major factors driving the global microfluidics medical devices market.

By Region: Microfluidic Devices Market and Forecast – Key Takeaways

North America accounted for largest share of the microfluidic devices market, followed by Europe. The active participation of research institutes in this region for the development of novel microfluidic devices is expected to maintain the region’s dominance. Also, the high incidence rate of lifestyle diseases and increasing demand for POC testing, is expected to propel growth of the microfluidic devices market over the forecast period.
In Europe, Germany, France, and United Kingdom are the leading market for microfluidic devices. The increasing demand for POC testing, growing preference for personalized medicine, growing need for high-speed diagnostics and an increasing number of drug discovery and life science research activities are driving the demand for microfluidic devices market.
Asia Pacific is the fastest growing market for microfluidic devices. Factors such as the growing geriatric population, increasing investments in the healthcare industry, rising demand for advanced technologies and the expansion of private–sector hospitals to rural areas in various countries in the region are driving the growth of microfluidic devices market.

iGATE RESEARCH report titled “Global Microfluidic Devices Market, By Device Type (Chips, Micro Pumps, Sensors, Micro Needles, Others), By Material (Silicon, Glass, Polymers, Others), By Application (Pharmaceuticals and Life Sciences Research, Clinical and Veterinary Diagnostics, Point of Care Diagnostics, Analytical Devices, Drug Delivery, Environmental and Industrial), By Industry (In–Vitro Diagnostics, Pharmaceuticals, Medical Devices, Others), Regional Analysis, Key Company Profiles, Trends and Recent Developments – Forecast to 2030” provides a comprehensive assessment of the fast–evolving, high–growth Global Microfluidic Devices Market.

This 176 Pages report with 83 Figures and 10 Tables has been analyzed from 10 viewpoints:

1. Global Microfluidic Devices Market and Forecast (2018 – 2030)
2. Global Microfluidic Devices Market Share and Forecast (2018 – 2030)
3. By Device Type – Global Microfluidic Devices Market and Forecast (2018 – 2030)
4. By Material – Global Microfluidic Devices Market and Forecast (2018 – 2030)
5. By Application – Global Microfluidic Devices Market and Forecast (2018 – 2030)
6. By Industry – Global Microfluidic Devices Market and Forecast (2018 – 2030)
7. By Region – Microfluidic Devices Market and Forecast (2018 – 2030)
8. Global Microfluidic Devices Market – Recent Developments
9. Global Microfluidic Devices Market – Key Company Profiles and Revenue
10. Global Microfluidic Devices Market Dynamics – SWOT Analysis, Key Trends, Growth Drivers & Challenges

By Device Type – Global Microfluidic Devices Market and Forecast

1. Chips
2. Micro Pumps
3. Sensors
4. Micro Needles
5. Others

By Material – Global Microfluidic Devices Market and Forecast

1. Silicon
2. Glass
3. Polymers
4. Others

By Application – Global Microfluidic Devices Market and Forecast

Pharmaceuticals and Life Sciences Research
Clinical and Veterinary Diagnostics
Point of Care Diagnostics
Analytical Devices
Drug Delivery
Environmental and Industrial
Others

By Industry – Global Microfluidic Devices Market and Forecast

1. In–Vitro Diagnostics
2. Pharmaceuticals
3. Medical Devices
4. Others

By Region – Microfluidic Devices Market and Forecast

1. North America

United States
Canada

2. Europe

Germany
France
Italy
Spain
United Kingdom
Netherlands
Switzerland
Belgium
Rest of Europe

3. Asia Pacific

Japan
China
India
Rest of Asia Pacific

4. Latin America

5. Middle East & Africa

Global Microfluidic Devices Market – Company Profiles

1. uFluidix
2. PerkinElmer, Inc. (Now Revvity, Inc.)
3. Standard BioTools Inc. (Previously Fluidigm)
4. Blacktrace Holdings Ltd. (Acquired by Unchained Labs)
5. Micronit
6. BioFluidix Gmbh (Acquired by Hamilton)
7. Hamilton Company
8. Fluigent
9. ALine Inc.
10. Koninklijke Philips N.V.
11. Danaher Corporation
12. Thermo Fisher Scientific Inc.
13. Agilent Technologies Inc.
14. Becton, Dickinson and Company (BD)
15. Illumina, Inc.
16. Abbott Laboratories
17. QuidelOrtho Corporation
18. Abaxis Inc. (Now part of Zoetis)
19. Nanōmix, Inc. (Formerly known as Covalent Materials, Inc.)
20. biosurfit SA
21. Micropoint Biotechnologies Co., Ltd.
22. Siloam Biosciences, Inc. (Acquired by MiCo BioMed)
23. NanoEnTek Inc.
24. OPKO Health, Inc.

Data Sources

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies:

Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies:

Printable and Non–printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.